Endothelium-derived nitric oxide is involved in the hypotensive and vasorelaxant effects induced by discretamine in rats

Pharmazie

Volumn 64, Issue 5, 2009, Pages 327-331

  Silva, D F ^a   Porto, D L ^a   Araujo I G A ^a   Dias, K L G ^a   Cavalcante, K V M ^a   Veras, R C ^a   Tavares, J F ^a   Correia, N A ^a   Guedes, D N ^a   Silva, M S ^a   De Medeiros, Isac Almeida ^a  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; DISCRETAMINE; GUANYLATE CYCLASE; HYDROXOCOBALAMIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; ANTIHYPERTENSIVE AGENT; BERBERINE DERIVATIVE; ENDOTHELIUM DERIVED RELAXING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; AORTA; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR SYSTEM; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; HEART CONTRACTION; HEART RATE; HEMODYNAMICS; HYPOTENSION; MALE; NONHUMAN; RABBIT; RAT; SUPERIOR MESENTERIC ARTERY; TACHYCARDIA; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION; ANIMAL; BLOOD PRESSURE; CELL CULTURE; DRUG EFFECT; MESENTERIC ARTERY; METABOLISM; MUSCLE RELAXATION; PHYSIOLOGY; WISTAR RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BERBERINE ALKALOIDS; BLOOD PRESSURE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; HEART RATE; MALE; MESENTERIC ARTERIES; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; RABBITS; RATS; RATS, WISTAR;

EID: 70349245092     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2009.8650     Document Type: Article

References (30)

1. Andrew PJ, Mayer B (1999) Enzymatic function of nitric oxide synthase. Cardiovasc Res 43: 521-531.
2. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
3. Bredt DS, Ferris CD, Snyder SH (1992) Nitric oxide synthase regulatory sites: phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. J Biol Chem 267: 10976-10981.
4. Chauhan S, Rahman A, Nilsson H, Clapp L, Macallister R, Ahluwalia A (2003) NO contributes to EDHF-like responses in rat small arteries: a role for NO stores. Cardiovasc Res 57: 207-216.
5. Chiou WF, Yen MH, Chen CF (1991) Mechanism of vasodilatory effect of berberine in rat mesenteric artery. Eur J Pharmacol 204: 35-40.
6. Chun YT, Yip TT, Lau KL, Kong YC, Sankawa U (1979) A biochemical study on the hypotensive effect of berberine in rats. Gen Pharmacol 10: 177-182.
7. Cui W, Iwasa K, Tozuda H, Kashihara A, Mitani Y, Hasegawa T, Nishiyama Y, Moriyasu M, Nishino H, Hanaoka M, Mukai C, Takeda K (2006) Potential cancer chemopreventive activity of simple isoquinolines, 1-benzylisoquinolines, and protoberberines. Phytochemistry 67: 70-79.
8. Fechine IMS, Da-Cunha EVL, Barbosa-Filho JM, Silva MS (2000) Tetrahydroprotoberberine and aporphine alkaloids from Rollinia leptopetala. Pharm Biol 38: 1-3.
9. Fechine IMS, Lima MA, Navarro VR, Da-Cunha EVL, Silva MS, Barbosa-Filho JM, Maia JGS (2002) Alcalóides de Duguetia trunciflora Maas (Annonaceae). Rev Brasil Farmacogn 12: 17-19.
10. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B (1995) Potent and selective inibition of nitric oxide sensitive guanylyl cyclase by 1H-[1,2,4] oxadiazolo [4,3-a] quinoxalin-1-one. Mol Pharmacol 48: 184-188.
11. Guedes DN, Silva DF, Barbosa-Filho JM, Medeiros IA (2002) Muscarinic agonist properties involved in the hypotensive and vasorelaxant responses of rotundifolone in rats. Planta Med 68: 700-704.
12. Guh JH, Hsieh CH, Teng CM (1999) Investigation of the effects of some alkaloidal a1-adrenoceptor antagonists on human hyperplastic prostate. Eur J Pharmacol 374: 503-510.
13. Hahn FE, Cuak J (1975) Berberine. In: Corcoran JW, Hahn FE (eds.) Antibiotics, vol. 3 Springer-Verlag, New York, p. 577-584.
14. Islam MM, Sinha R, Kumar GS (2007) RNA binding small molecules: studies on t-RNA binding by cytotoxic plant alkaloids berberine, palmatine and the comparison to ethidium. Biophys Chem 125: 508-520.
15. Iwasa K, Nanba H, Lee D-U, Kang S-I (1998b) Structure-activity relationships of protoberberines having antimicrobial activity. Planta Med 64: 748-751.
16. Iwasa K, Moriyasu M, Tachibana Y, Kim H-S, Wataya Y, Wiegrebe W, Bastow KF, Cosentino LM, Kozuka M, Lee KH (2001a) Simple isoquinoline and benzylisoquinoline alkaloids as potenial antimicrobial, antimalarial, cytotoxic, and anti-HIV agents. Bioorg Med Chem 9: 2871-2884.
17. Iwasa K, Moriyasu M, Yamori T, Turuo T, Lee D-U, Wiegrebe W (2001b) In vitro cytotoxicity of the protoberberine-type alkaloids. J Nat Prod 64: 896-898.
18. Ko FN, Yu SM, Su MJ, Wu YC, Teng CM (1993) Pharmacological activity of (-)-discretamine, a novel vascular alpha-adrenoceptor and 5-hydroxytryptamine receptor antagonist, isolated from Fissistigma glaucescens. Br J Pharmacol 110: 882-888.
19. Ko FN, Guh JH, Yu SM, Hou YS, Wu YC, Teng CM (1994) (-) Discretamine, a selective a1D-adrenoceptor antagonist, isolated from Fissistigma glaucescens. Br J Pharmacol 112: 1174-1180.
20. Ko W-H, Yao X-Q, Lau C-W, Lawm W-I, Chen Z-Y (2000) Kwok W et al. Vasorelaxant and antiproliferative effects of berberine. Eur J Pharmacol 399: 187-196.
21. Kruszyna H, Magyar JS, Rochelle LG, Russel MA, Smith RP, Wilcox DE (1998) Spectroscopic studies of nitric oxide (NO) interactions with cobalamins: Reaction of NO wit superoxocobalamin (III) likely accounts for cobalamin reversal of the biological effects of NO. J Pharmacol Exp Ther 285: 665-671.
22. Leite PF, Danilovic A, Moriel P, Dantas K, Marklund S, Dantas AP, Laurindo FR (2003) Sustained decrease in superoxide dismutase activity underlies constrictive remodeling after balloon injury in rabbits. Arterioscler Thromb Vasc Biol 23: 2197-2202.
23. Moncada S, Vane JR (1979) Pharmacology and endogenous roles ofprostaglandins endoperoxydes, throboxane A2 and prostacyclin.Pharmacol Rev 30: 293-331.
24. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-42.
25. Nishino H, Kitagawa K, Fujiki H, Iwashima A (1986) Berberine sulfate inhibits tumor-promoting activity of teleocidin in two-stage carcinogenesis on mouse skin. Oncology 43: 131-134.
26. Orallo F, Garcia-Ferreiro T, Enguix MJ, Tristan H, Masaguer C, Ravina E, Cadavid I, Loza MI (2003) In vivo and in vitro pharmacological studies of a new hypotensive compound (QF0301B) in rat: comparison with prazosin, a known a1-adrenoceptor antagonist. Vasc Pharmacol 40: 97-108.
27. Ress DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S (1990) Characterisation of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101: 746-752.
28. Shaffer JE (1985) Inotropic and chronotropic activity of berberine on isolated guinea-pig atria. J Cardiovasc Pharmacol 7: 307-315.
29. Tanabe H, Suzuki H, Nagatsu A, Mizukami H, Ogihara Y, Inoue M (2006) Selective inhibition of vascular smooth muscle cell proliferation by coptisine isolated from Coptis rhizoma, one of the crude drugs composing Kampo medicines Unsei-in. Phytomedicine 13: 334-42.
30. Yamamoto K, Takase H, Abe K, Saito Y, Suzuki A (1993) Pharmacological studies on antidiarrhoeal effects of a preparation containing berberine and gerainiiherba. Nippon Yakurigaku Zasshi 101: 169-175.